Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and roughly 100,000 here in the United States, most of them African American. It ...
Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies 90% (9 of 10) of patients were able to ...
Despite a Trump administration push, there are few facilities offering the complex treatment in the rural areas where many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback